Episódios
-
Join Isabel and Jade for this special episode of the GOLD podcast as three of last year's guests share their predictions for the pharmaceutical industry in 2024. The panel includes Matt Lewis from Inizio, Rick Hollis from Ipsen and Claudia Martinez from the Access to Medicine Foundation, all of whom share their predictions in their areas of expertise.
But that's not all. The GOLD hosts also reminisce about the team's 2023 predictions podcast to see if these guests could really see the future.
-
The Season 6 finale of the GOLD podcast has landed! Tune in to hear Isabel and Jade present a discussion with Kinnari Patel, President and Chief Operating Officer, Rocket Pharmaceuticals.
In this episode, Kinnari shares her thoughts on how the industry can engage the next generation of scientific leaders to propel itself into the future. Tune in to find out what might be stopping the younger generation from pursuing a career in pharma and how the industry can work to change their minds, the benefits of a more diverse workforce, the future of drug development and more.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Mastering medical affairs
Taking women to the top of pharma
Do happy employees equal better innovation?
Last week's podcast: A patient's right to thrive, not just survive
-
Estão a faltar episódios?
-
Tune in to the latest episode of the GOLD podcast which sees Isabel sit down for a chat with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb.
In the episode, Wendy discusses her passion for developing life-saving cancer drugs with less toxic side effects. Learn about how far the industry has come, while being guided through the ways in which the sector could still evolve for the benefit of patients.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Going for gold in gynaecological cancers Mental health matters in pharma's approach to care Last week's podcast: What motivates and challenges GOLD's guests? -
Tune in for a sneak peek of GOLD's latest Catalyst interview with Dr Peter Ahnesorg, Global Hematology Franchise Head, Roche. In this exclusive teaser of the full interview, Peter talks about why he left research for industry, Roche's commitment to ensuring equitable access to its medicines and what he believes are the qualities of a good leader today. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: Podcast: Changing the tide on health inequities Podcast: Do happy employees equal better innovation? Last week’s podcast: A high-speed chase for oncology innovation
-
Tune in to the latest episode of the GOLD podcast as Isabel and Jade present a discussion with Jaime Manzanera Gómez, EMEA Brand Director, Oncology, Eisai, who details how oncology teams can best increase the pace of innovation in the field.
In this episode, Jaime shares his thoughts on the pace of innovation after the heights of COVID-19, how regulatory constraints can sometimes affect the industry's thirst for innovation, his passion for the outdoors and much more.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Do happy employees equal better innovation? Going for gold in gynaecological cancers Last week's podcast: Changing the tide on health inequities -
Listen in to the newest episode of the GOLD podcast, in which Jade digs deep into the diversity, equity and inclusion (DE&I) space with Marion Brooks, Vice President and US Country Head, Diversity, Equality and Inclusion, Novartis.
In the interview, the pair discuss why Marion left a career in commercial for DE&I, the need for more action on health inequities, Novartis's approach to creating a more diverse medical workforce and much more.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Roche's Davidek Herron: My journey with diversity, equity and inclusion 4 top tips to create the perfect ERG Last week's podcast: Why HCPs are losing trust in pharma marketing -
Tune in to a new episode of the GOLD podcast as hosts Isabel and Jade discuss a timely topic for the pharmaceutical industry: how to build trust with healthcare professionals.
With a recent survey showing that 80% of HCPs don't trust the content the industry produces for them, the team look at the story behind the statistic. They explore where the problems lie and how the industry can improve for the benefit of its customers.
GOLD also hears from Rob Verheul, CEO, Graphite Digital, the company behind the report, who shares his takeaways from the research. These include the importance of data accuracy, the value of a good customer experience, top tips for building trust and more.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Conquering generational differences in HCP marketing Meeting customer needs in medical affairs Getting to grips with customer experience -
Tune in to the latest instalment of the GOLD podcast, which sees Isabel and Jade present a conversation with Rick Hollis, Director of Business Excellence, Ipsen, about his views on how the pharmaceutical industry's customer engagement model needs to grow and evolve.
Discover the highs and lows of creating meaningful marketing interactions with this week's guest as Rick explores the evolution of customer engagement, his top tips for creating more enticing communications, his vision for a customer experience utopia and more.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Upgrading the personal touch in CX Getting to grips with customer engagement Last week’s podcast: Investigating the reality of rare disease research -
Discover the reality behind the expectations of rare disease research and drug development with Isabel and Jade as they present a discussion with Dr Ian Winburn, Vice President, Global Lead for Rare Hematology, Pfizer. Tune in to hear Ian and Isabel discuss the current pharmaceutical landscape for rare diseases, including discussions around clinical trials, partnering early in the drug lifecycle, what the industry should be keeping in mind for the future of the field and much more. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: Mitigating the rare disease RWD deficit Last week’s podcast: Do happy employees equal better innovation
-
Tune in to the latest episode of the GOLD podcast as Nate Cope, Chief Operating Officer, Otsuka Europe, details how companies can drive innovation by being a great place to work.
In this episode, Nate reveals the story behind his passion for prioritising people, what companies should and shouldn't do in their mission to become more people-centric and an example of how Otsuka sought to reward its employees for getting better sleep.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
4 top tips to create the perfect ERG The driving seat of organisational change Last week's podcast: Taking the pulse of digital health -
The GOLD podcast is back on the airwaves! Join Isabel and Jade every Tuesday as they speak to a new bunch of inspiring leaders from the pharmaceutical industry. The first interviewee of the season is Parveen Jayia, Therapy Area Head, Breast and Gynaecological Cancers, AstraZeneca, who talks to GOLD about the role digital health can play in the future of the industry. From working with policymakers to designing the perfect digital health strategy, tune in to hear her top tips for staying ahead of the curve.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
AI, ChatGPT and modernising medical affairs Inspiring innovation and the future of digital therapeutics Going for gold in gynaecological cancersThe opinions and views expressed here are her personal and do not necessarily reflect the opinions or views of AstraZeneca or any subsidiary thereof.
-
In this final GOLD Nugget of the series, Jade reflects on her conversation with season finale guest Christy Seigel, General Manager, Breast and Women's Cancers Portfolio, Novartis US Oncology, from her episode ‘Going the extra mile for patients with disabilities’.
In this episode, Jade picks out her favourite anecdote Christy shared, which was how her experience of raising children with disabilities helped her to push for better disability inclusion within the pharmaceutical industry.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Christy’s full episode: Season finale: Going the extra mile for patients with disabilities - GOLD (emg-gold.com)
Going for gold in gynaecological cancers
-
It is time for the third ‘GOLD nugget’ from Season 5, and Jade is highlighting her favourite insight shared by Sarah Jarvis, Global Lead for the Medical Consulting Practice, ZS, from her episode with colleague Sunil John, ‘Meeting customer needs in medical affairs’.
In this clip, Sarah shares findings from ZS's latest Medical Affairs Outlook report and details what medical education healthcare professionals want from the industry at each phase of the product lifecycle.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Sarah’s full episode: https://www.emg-gold.com/post/meeting-customer-needs-in-medical-affairs
Revealing the true value of medical affairs: https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs
-
In the second episode of GOLD nuggets, Isabel looks back at her conversation with Dr Sunil Verma, Global Head of Oncology, Medical, AstraZeneca, in which the two discussed the journey to transforming cancer care.
In this particular clip, Sunil delves into what motivates him to wake up in the morning and what industry challenge can keep him awake at night.
Additional resources
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Sunil’s full episode: What will it take to transform cancer care? - GOLD (emg-gold.com)Mapping a path to personalised medicine Mapping a path to personalised medicine - GOLD (emg-gold.com) -
As the GOLD team prepare for the next season of the podcast, take a walk down memory lane with Isabel and Jade as they share their GOLD Nuggets from Season 5.
In the first of these special bonus episodes, Isabel looks back at the very first episode of Season 5, featuring Philippe Kirby, Global Head of Channel Engagement and Execution, MSD. Isabel pulls out her favourite insight Philippe shared: how pharma teams can best gather information from HCPs to improve their customer experience.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: Philippe’s full episode: Getting to grips with customer engagement Upgrading the personal touch in CX -
To bring season 5 of the GOLD podcast to a close, join Jade as she sits down with Christy Seigel, General Manager, Breast and Women’s Cancers Portfolio, Novartis US Oncology, to discuss the importance of disability inclusion in the pharmaceutical industry.
In this episode, Jade and Christy unpick her transition from general medicine to women’s cancer, how companies can best extend oncology care to those with disabilities, ways to expand diversity, equity and inclusion schemes to better support those living with disabilities and more.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Going for gold in gynaecological cancers: https://www.emg-gold.com/post/going-for-gold-in-gynaecological-cancers
4 top tips to create the perfect ERG: https://www.emg-gold.com/post/4-top-tips-to-create-the-perfect-employee-resource-group
Translating policy into action: https://www.emg-gold.com/post/translating-policy-into-action
Last week’s episode: https://www.emg-gold.com/post/season-5-highlights-gold-medal-moments
-
As Season 5 of the GOLD podcast approaches its end, join Isabel and Jade as they share some of the most memorable moments from the last couple of months.
Join our hosts for a trip down memory lane as they look back on their ‘GOLD Medal Moments’ in the penultimate episode of the season. They cover topics such as the importance of avoiding tokenism, the value of personalisation, investing in customer experience and much more.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
My journey with diversity, equity and inclusion https://www.emg-gold.com/post/my-journey-with-diversity-equity-and-inclusion
Cell and gene therapy: a victim of its own success https://www.emg-gold.com/post/cell-and-gene-therapy-a-victim-of-its-own-success
Mapping a path to personalised medicine https://www.emg-gold.com/post/mapping-a-path-to-personalised-medicine
Conquering generational differences in HCP marketing https://www.emg-gold.com/post/conquering-generational-differences-in-hcp-marketing
Upgrading the personal touch in CX https://www.emg-gold.com/post/upgrading-the-personal-touch-in-cx
- Mostrar mais